Elizabeth A. Garofalo is of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 0 shares of XENE, which is worth approximately $0. The most recent transaction as insider was on Mar 08, 2024, when has been sold 2,092 shares (Common Shares) at a price of $45.69 per share, resulting in proceeds of $95,583. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

ELIZABETH A. GAROFALO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2024
SELL
Open market or private sale
$95,583 $45.69 p/Share
2,092 Reduced 100.0%
0 Common Shares
Mar 08 2024
SELL
Payment of exercise price or tax liability
$64,993 $46.16 p/Share
1,408 Reduced 40.23%
2,092 Common Shares
Mar 08 2024
BUY
Exercise of conversion of derivative security
$64,959 $18.56 p/Share
3,500 Added 50.0%
3,500 Common Shares

Also insider at

ACAD
ACADIA PHARMACEUTICALS INC Healthcare
XCUR
EXICURE, INC. Healthcare
ALEC
Alector, Inc. Healthcare
EAG

Elizabeth A. Garofalo

San Diego, CA

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Track Activities on XENE